Home » Topics » BioWorld Science

BioWorld Science
RSS

Sankyo prepares pseudomonic acid derivatives

Nov. 1, 1996

Potent antifungal agent described by Morishita Roussel

Nov. 1, 1996

New antibiotic from Sankyo

Nov. 1, 1996

Advanced Polymer Systems and Medicis sign agreement for dermatology products

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Hybridon researches VEGF/VPF antisense compounds for skin disorders

Nov. 1, 1996

Roche describes retinoid compounds for acne, cancer

Nov. 1, 1996

Spotlight on NK1 antagonists

Nov. 1, 1996

New method of total synthesis of epibatidine reported

Nov. 1, 1996

Lanepitant in clinical trials for pain

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...